CenterWatch

Psoriasis and Psoriatic Disorders Clinical Trials

A listing of Psoriasis and Psoriatic Disorders medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Alabama

Arizona

Arizona Arthritis & Rheumatology Research, PLLC
Glendale Arizona 85304

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Arizona Research Center
Phoenix Arizona 85023

A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214(Study Medication) Versus Enbrel in Subjects With Chronic Plaque Psoriasis.

California

University of California, Irvine Dermatology Clinical Research Center
Irvine California

A Multi-Center, Open Label, Phase 1 Study to Evaluate the Safety of Both A Prospective, Observational Study to Estimate the Proportion of Subjects with Plaque Psoriasis who Achieve Complete Clearance on Biologics

University of California, Irvine Dermatology Clinical Research Center
Irvine California 92697

Open Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects with Moderate to Severe Plaque Psoriasis Who Have Lost a Satisfactory Response to Adalimumab

Dermatology Research Associates
Los Angeles California 90045

Efficacy of Ustekinumab (Anti-IL-12/23) followed by Abatacept (CTLA4-Ig)for the Treatment of Psoriasis Vulgaris (PAUSE)

Dermatology Specialists, Inc.
Oceanside California 92056

A national, multi-center, randomized, double-blind, 4 arm, 8 week study in subjects with psoriasis vulgaris on the non-scalp regions of the body (trunk and/or limbs)

Dermatology Specialists, Inc.
Oceanside California 92056

A Phase 3, Multi-site, randomized, mixed-blind, parallel-group treatment withdrawl and re-treatment study of the efficacy and safety of 2 oral doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis

Dermatology Specialists, Inc.
Oceanside California 92056

You may be interested in learning about a clinical research study of an investigational study medication for symptoms associated with plaque psoriasis

Stanford University School of Medicine
Palo Alto California 94304

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Connecticut

New England Research Associates, LLC
Trumbull Connecticut 06611

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Florida

Rheumatology Associates of Central Florida, PA
Orlando Florida 32806

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Millennium Research
Ormond Beach Florida 32174

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Arthritis Center, Inc.
Palm Harbor Florida 34684

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

University of South Florida - Morsani Center for Advance Healthcare
Tampa Florida 33612

A multicenter open label uncontrolled study of the long term safety and efficacy of calcitriol 3mcg/g ointment applied twice daily for 26 weeks in pediatric subjects (2 to 17 years of age) with mild to moderate plaque psoriasis

University of South Florida - Morsani Center for Advance Healthcare
Tampa Florida 33612

A Phase 3, Multicenter, Double-Blind, Randomized, Parallel-Arm, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Adalimumab for Treatment of Nail Psoriasis in Subjects With Chronic Plaque Psoriasis

Olympian Clinical Research
Tampa Florida 33609

Do you have plaque-type psoriasis?

University of South Florida - Morsani Center for Advance Healthcare
Tampa Florida 33612

Effect of Calcipotriol plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 months) with Scalp and Body Psoriasis

Georgia

Advanced Medical Research
Atlanta Georgia 30342

Do you have moderate-to-severe plaque-type psoriasis?

Advanced Medical Research, Inc.
Atlanta Georgia 30342

Do you have plaque-type psoriasis?

Columbus Regional Research Institute
Columbus Georgia 31904

Considering potential research options for managing psoriasis?

Medaphase, Inc
Newnan Georgia 30263

Do you have plaque-type psoriasis?

Illinois

Northwestern University
Chicago Illinois 60611

Efficacy of Ustekinumab (Anti-IL-12/23) followed by Abatacept (CTLA4-Ig)for the Treatment of Psoriasis Vulgaris (PAUSE)

Indiana

Dawes Fretzin Clinical Research Group, LLC
Indianapolis Indiana 46256

Do you have moderate-to-severe plaque-type psoriasis?

Indiana Clinical Trials Center
Plainfield Indiana 46168

Do you have moderate-to-severe plaque-type psoriasis?

Kentucky

Dermatology Specialists
Louisville Kentucky 40202

Do you have moderate-to-severe plaque-type psoriasis?

Maryland

The Center For Rheumatology And Bone Research
Wheaton Maryland 20902

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Massachusetts

ORA, Inc
Andover Massachusetts 1810

Do you have plaque-type psoriasis?

Brigham & Women's Hospital
Boston Massachusetts 02115

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Tufts Medical Center
Boston Massachusetts 02111

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Clinical Pharmacology Study Group
Worcester Massachusetts 01605

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Michigan

University of Michigan
Ann Arbor Michigan 48109

Efficacy of Ustekinumab (Anti-IL-12/23) followed by Abatacept (CTLA4-Ig)for the Treatment of Psoriasis Vulgaris (PAUSE)

Somerset Skin Centre
Troy Michigan 48084

Do you have plaque-type psoriasis?

Minnesota

Missouri

Clayton Medical Research
St. Louis Missouri 63117

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Central Dermatology
St. Louis Missouri 63376

Do you have plaque-type psoriasis?

Nebraska

Physician Research Collaboration, LLC
Lincoln Nebraska 68516

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Nevada

New Jersey